跳至主要内容
临床试验/NCT04222361
NCT04222361Unknown不适用

Prevention of Acute Renal Injury in the Septic Patient by Implementing the KDIGO Guideline in High-risk Patients Identified by Biomarkers

Hospital General Universitario Elche2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
Compare the incidence of moderate-severe acute renal injury

研究概览

简要总结

Summary: Controlled, prospective, randomized and randomized clinical trial of two intervention groups (standard care vs. preventive recommendations the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for AKI) of patients diagnosed with sepsis and abdominal post-surgical septic shock with positive results in the risk determination of acute renal injury by NephroCheck® Test that integrates the urinary biomarkers TIMP-2 and IGFBP-7.

Hypothesis: The implementation of a package of preventive measures proposed by the KDIGO guide can reduce the occurrence and severity of acute renal injury in the high-risk abdominal post-surgical septic patient detected by urinary biomarkers for early detection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years.
  • Patients (or their informed family members) who accept and sign the informed consent.
  • Patients diagnosed with sepsis or abdominal post-surgical septic shock.

排除标准

  • Patients under 18 years.
  • Patients (or their authorized relatives) who refuse to sign the informed consent.
  • Patients diagnosed with sepsis or non-surgical septic shock.
  • Patients diagnosed with sepsis or septic shock of origin other than abdominal.
  • Patients with AKI stages KDIGO 2 and 3 and / or renal replacement therapy.
  • Patients with chronic renal failure and glomerular filtration <30 ml / min and / or undergoing treatment with dialysis or previous renal transplantation.
  • Patients with AKI of origin other than the diagnosed septic, such as glomerulonephritis or interstitial nephritis, renal artery occlusion and / or postrenal obstruction.

结局指标

主要结局

Compare the incidence of moderate-severe acute renal injury

时间窗: 72 hours

Compare the incidence of moderate-severe acute renal injury (stages KDIGO 2 and 3) in the first 72 hours of diagnosis of sepsis and septic post-surgical septic shock in patients at high risk of AKI determined by NephroCheck® Test (those with a ≥0.3 ng / ml2 / 1000 result) that the package of preventive measures proposed by the KDIGO guideline is applied vs. standard treatment

次要结局

  • Compare the number of participants in need of renal replacement therapy(90 days)
  • Compare the number of days of stay in the Surgical ICU(90 days)
  • Compare mortality from any cause(90 days)
  • Compare the number of participants with persistent renal dysfunction(90 days)
  • Compare the number of days of stay in the hospital(90 days)
  • Measure the incidence of development of AKI in patients at low risk of AKI determined by NephroCheck® Test(72 hours)

研究者

发起方
Hospital General Universitario Elche
申办方类型
Other
责任方
Principal Investigator
主要研究者

María Mercader Alarcón

Principal Investigator

Hospital General Universitario Elche

研究点 (2)

Loading locations...

相似试验